ClinDatrix is Different
ClinDatrix is a CRO serving the pharmaceutical, biotechnology and medical device industries globally. We provide world-class performance and quality at a moderate price.
Services
From our inception, the ClinDatrix vision has been to offer comprehensive, world-class CRO services to innovators in the pharmaceutical, biotechnology and medical device industries. Through our U.S.-based staff and global affiliates, we are a trusted choice for firms conducting Phase I-IV trials domestically or around the world.
Our core strengths enable us to guide our clients so that their studies yield accurate, reliable data. Our workflow processes and procedures are governed by a full suite of SOPs that are compliant with GCPs and ICH and FDA guidelines. We utilize advanced equipment and systems including Oracle InForm for global electronic data capture (EDC). All of our GxP systems are fully validated and managed using change control.
Everything ClinDatrix does, from protocol review and CRF design to clinical study reports and regulatory submissions, helps advance our clients along their product development pathways.
Leadership
ClinDatrix leverages the successful career experience and extensive knowledge of its founders, Louise M. Murphy, President and CEO, and Brian G. Murphy, CFO and Chairman of the Board, to advance our clients’ clinical research.
Today the firm employs an executive management team whose members each have an average of 20 years of industry experience and 10 advanced degrees among them. Utilizing the team’s strong project management skills and expertise honed by hands-on experience, ClinDatrix works in partnership with our clients to deliver excellent contract research services.